Durable complete response to immunotherapy with anti-PD-1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report

被引：3

作者：

Sekido, Katsuhisa ^{[1
,2
]}

Imaue, Shuichi ^{[1
]}

Tomihara, Kei ^{[1
]}

Tachinami, Hidetake ^{[1
]}

Yamagishi, Kentaro ^{[3
]}

Okazawa, Seisuke ^{[4
]}

Ikeda, Atsushi ^{[1
]}

Fujiwara, Kumiko ^{[1
]}

Noguchi, Makoto ^{[1
]}

机构：

[1] Univ Toyama, Dept Oral & Maxillofacial Surg, Fac Med, Toyama, Japan

[2] Toyama Red Cross Hosp, Dept Oral & Maxillofacial Surg, Toyama, Japan

[3] Univ Toyama, Dept Radiol, Fac Med, Toyama, Japan

[4] Univ Toyama, Dept Internal Med 1, Fac Med, Toyama, Japan

来源：

CLINICAL CASE REPORTS | 2021年 / 9卷 / 09期

关键词：

anti-PD-1; complete remission; immune checkpoint inhibitor; lung metastasis; nivolumab; oral squamous cell carcinoma; DISTANT METASTASES; HEAD; NECK; CETUXIMAB; RECURRENT; RESECTION;

D O I：

10.1002/ccr3.4545

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Although the optimal treatment method for metastatic oral cancer remains largely unknown, the present case suggests that immunotherapy is a potentially promising alternative for metastatic oral cancer in which other therapies are no longer effective.

引用

收藏

页数：5

相关论文

共 19 条

[1] Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck - An analysis of two Eastern Cooperative Oncology Group randomized trials [J].

Argiris, A ;

Li, Y ;

Forastiere, A .

CANCER, 2004, 101 (10) :2222-2229

[2] Pulmonary resection for metastatic head and neck cancer [J].

Chen, Fengshi ;

Sonobe, Makoto ;

Sato, Kiyoshi ;

Fujinaga, Takuji ;

Shoji, Tsuyoshi ;

Sakai, Hiroaki ;

Miyahara, Ryo ;

Bando, Toru ;

Okubo, Kenichi ;

Hirata, Toshiki ;

Date, Hiroshi .

WORLD JOURNAL OF SURGERY, 2008, 32 (08) :1657-1662

[3] Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response [J].

Diggs, Laurence P. ;

Hsueh, Eddy C. .

BIOMARKER RESEARCH, 2017, 5

[4]

Edward C. H., 2013, PEREZ BRADYS PRINCIP

[5] Incidence and sites of distant metastases from head and neck cancer [J].

Ferlito, A ;

Shaha, AR ;

Silver, CE ;

Rinaldo, A ;

Mondin, V .

ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 2001, 63 (04) :202-207

[6] Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck [J].

Ferris, R. L. ;

Blumenschein, G., Jr. ;

Fayette, J. ;

Guigay, J. ;

Colevas, A. D. ;

Licitra, L. ;

Harrington, K. ;

Kasper, S. ;

Vokes, E. E. ;

Even, C. ;

Worden, F. ;

Saba, N. F. ;

Iglesias Docampo, L. C. ;

Haddad, R. ;

Rordorf, T. ;

Kiyota, N. ;

Tahara, M. ;

Monga, M. ;

Lynch, M. ;

Geese, W. J. ;

Kopit, J. ;

Shaw, J. W. ;

Gillison, M. L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) :1856-1867

[7] SQUAMOUS-CELL CARCINOMA OF ORAL SOFT-TISSUES - STATISTICAL-ANALYSIS OF 14,253 CASES BY AGE, SEX, AND RACE OF PATIENTS [J].

KROLLS, SO ;

HOFFMAN, S .

JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1976, 92 (03) :571-574

[8] Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma [J].

Leblanc, Olivia ;

Vacher, Sophie ;

Lecerf, Charlotte ;

Jeannot, Emmanuelle ;

Klijanienko, Jerzy ;

Berger, Frederique ;

Hoffmann, Caroline ;

Calugaru, Valentin ;

Badois, Nathalie ;

Chilies, Anne ;

Lesnik, Maria ;

Krhili, Samar ;

Bieche, Ivan ;

Le Tourneau, Christophe ;

Kamal, Maud .

CANCER BIOLOGY & MEDICINE, 2020, 17 (01) :208-+

[9] Squamous cell carcinoma of the buccal mucosa: An aggressive cancer requiring multimodality treatment [J].

Lin, C ;

Jen, YM ;

Cheng, MF ;

Lin, YS ;

Su, WF ;

Hwang, JM ;

Chang, UP ;

Chao, HL ;

Liu, DW ;

Lin, H ;

Shum, WY .

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2006, 28 (02) :150-157

[10] Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events [J].

Nakamura, Yoshiyuki .

FRONTIERS IN MEDICINE, 2019, 6 :1-18